A Prospective, Randomized, Blinded, Placebo-Controlled Pilot Study on the Effect of Enterococcus faecium on Clinical Activity and Intestinal Gene Expression in Canine Food-Responsive Chronic Enteropathy

Journal of Veterinary Internal Medicine

Volumn 29, Issue 2, 2015, Pages 533-543

  Schmitz, Silke ^a   Glanemann, B ^a   Garden, O A ^a   Brooks, H ^a   Chang, Y M ^a   Werling, D ^a   Allenspach, K ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Diarrhea; Dog; Inflammatory bowel disease; Probiotics

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; ENTEROCOCCUS FAECIUM;

PROBIOTIC AGENT;

ANIMAL; CONTROLLED STUDY; DOG; DOG DISEASES; ENTEROCOCCUS FAECIUM; FEMALE; GENE EXPRESSION REGULATION; INTESTINAL DISEASES; MALE; MICROBIOLOGY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; VETERINARY;

ANIMALS; DOG DISEASES; DOGS; ENTEROCOCCUS FAECIUM; FEMALE; GENE EXPRESSION REGULATION; INTESTINAL DISEASES; MALE; PILOT PROJECTS; PROBIOTICS;

EID: 84925658575     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/jvim.12563     Document Type: Article

References (46)

1. Allenspach K, Wieland B, Gröne A, Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med 2007;21:700-708.
2. Jergens AE, Moore FM, Haynes JS, Miles KG. Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987-1990). J Am Vet Med Assoc 1992;201:1603-1608.
3. German AJ, Hall EJ, Day MJ. Chronic intestinal inflammation and intestinal disease in dogs. J Vet Intern Med 2003;17:8-20.
4. Suchodolski JS, Xenoulis PG, Paddock CG, et al. Molecular analysis of the bacterial microbiota in duodenal biopsies from dogs with idiopathic inflammatory bowel disease. Vet Microbiol 2010;142:394-400.
5. Suchodolski JS, Markel ME, Garcia-Mazcorro JF, et al. The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PLoS ONE 2012;7:e51907.
6. Xenoulis PG, Palculict B, Allenspach K, et al. Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS Microbiol Ecol 2008;66:579-589.
7. van Baarlen P, Troost FJ, van Hemert S, et al. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci USA 2009;106:2371-2376.
8. Di Caro S, Tao H, Grillo A, et al. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis 2005;37:320-329.
9. Foligne B, Zoumpopoulou G, Dewulf J, et al. A key role of dendritic cells in probiotic functionality. PLoS ONE 2007;2:e313.
10. Thomas CM, Versalovic J. Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes 2010;1:148-163.
11. Shida K, Nanno M, Nagata S. Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes 2011;2:109-114.
12. Bellavia M, Rappa F, Lo Bello M, et al. Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2, 4, 6-trinitrobenzenesulfonic acid treatment in mice. J Biol Regul Homeost Agents 2014;28:251-261.
13. Jeon SG, Kayama H, Ueda Y, et al. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog 2012;8:e1002714.
14. Linskens RK, Huijsdens XW, Savelkoul PH, et al. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl 2001;234:29-40.
15. Sauter SN, Benyacoub J, Allenspach K, et al. Effects of probiotic bacteria in dogs with food responsive diarrhoea treated with an elimination diet. J Anim Physiol Anim Nutr (Berl) 2006;90:269-277.
16. Rossi G, Pengo G, Caldin M, et al. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PLoS ONE 2014;9:e94699.
17. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008;105:16731-16736.
18. Marcináková M, Klingberg TD, Lauková A, Budde BB. The effect of pH, bile and calcium on the adhesion ability of probiotic enterococci of animal origin to the porcine jejunal epithelial cell line IPEC-J2. Anaerobe 2010;16:120-124.
19. Marcináková M, Simonová M, Strompfová V, Lauková A. Oral application of Enterococcus faecium strain EE3 in healthy dogs. Folia Microbiol. (Praha) 2006;51:239-242.
20. Washabau RJ, Day MJ, Willard MD, et al. Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. J Vet Intern Med 2010;24:10-26.
21. Day MJ, Bilzer T, Mansell J, et al. Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group. J Comp Pathol 2008;138(Suppl 1):S1-S43.
22. Procoli F, Mõtsküla PF, Keyte SV, et al. Comparison of histopathologic findings in duodenal and ileal endoscopic biopsies in dogs with chronic small intestinal enteropathies. J Vet Intern Med 2013;27:268-274.
23. Schmitz S, Henrich M, Neiger R, et al. Stimulation of duodenal biopsies and whole blood from dogs with food-responsive chronic enteropathy and healthy dogs with toll-like receptor ligands and probiotic Enterococcus faecium. Scand J Immunol 2014;80:85-94.
24. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-386.
25. Vandesompele J, de Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
26. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010;10:133-141.
27. Tyrer P, Foxwell AR, Cripps AW, et al. Microbial pattern recognition receptors mediate M-cell uptake of a gram negative bacterium. Infect Immun 2006;74:625-631.
28. Cario E. Heads up! How the intestinel epithelium safeguards mucosal barrier immunity through the inflammasome and beyond. Curr Opin Gastroenterol 2010;26:583-590.
29. Hirota K, Martin B, Veldhoen M. Development, regulation and functional capacities of Th17 cells. Semin Immunopathol 2010;32:3-16.
30. Kanai T, Mikanmi Y, Sujuno T, et al. RORyt-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation. Mucosal Immunol 2012;5:240-247.
31. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
32. Fontenot JD, Gavin MA, Rudensky AY. FoxP3 programs the development and function of CD4 + CD25 + regulatory T-cells. Nat Immunol 2003;4:330-336.
33. Thim L. Trefoil peptides: from structure to function. Cell Mol Life Sci 1997;53:888-903.
34. Wahli W, Michalik L. PPARs at the crossroads of lipid signalling and inflammation. Trends Endocrinol Metab 2012;23:351-363.
35. Are A, Aronsson L, Wang S, et al. Enterococcus faecalis from newborn babies regulates endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells. Proc Natl Acad Sci USA 2008;106:1943-1948.
36. Schreiner NMS, Gaschen F, Gröne A, et al. Clinical signs, histology, and CD3-positive cells before and after treatment of dogs with chronic enteropathies. J Vet Intern Med 2008;22:1079-1083.
37. Mandigers PJJ, Biourge V, van den Ingh TSGAM, et al. A randomized, open-label, positively-controlled field trial of a hydrolyzed protein diet in dogs with chronic small bowel enteropathy. J Vet Intern Med 2010;24:1350-1357.
38. Walker D, Knuchel-Takano A, McCutchan A, et al. A comprehensive pathological survey of duodenal biopsies from dogs with diet-responsive chronic enteropathy. J Vet Intern Med 2013;27:862-874.
39. Allenspach K, House A, Smith K, et al. Evaluation of mucosal bacteria and histopathology, clinical disease activity and expression of Toll-like receptors in German shepherd dogs with chronic enteropathies. Vet Microbiol 2010;146:326-335.
40. Luckschander N, Allenspach K, Hall J, et al. Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease. J Vet Intern Med 2006;20:221-227.
41. Gaschen L, Kircher P, Stüssi A, et al. Comparison of ultrasonographic findings with clinical activity index (CIBDAI) and diagnosis in dogs with chronic enteropathies. Vet Radiol Ultrasound 2008;49:656-664.
42. McMahon LA, House AK, Catchpole B, et al. Expression of Toll-like receptor 2 in duodenal biopsies from dogs with inflammatory bowel disease is associated with severity of disease. Vet Immunol Immunopathol 2010;135:158-163.
43. Burgener IA, König A, Allenspach K, et al. Upregulation of toll-like receptors in chronic enteropathies in dogs. J Vet Intern Med 2008;22:553-560.
44. Schmitz S, Hill S, Werling D, Allenspach K. Expression of trefoil factor genes in the duodenum and colon of dogs with inflammatory bowel disease and healthy dogs. Vet Immunol Immunopathol 2013;151:168-172.
45. Jergens AE, Sonea IM, O'Connor AM, et al. Intestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta-analysis with critical appraisal. Comp Med 2009;59:153-162.
46. Jergens AE, Crandell J, Morrison JA, et al. Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial. J Vet Intern Med 2010;24:269-277.